title: [Evaluation of the quality of medical care in primary care patients with metabolic syndrome].
abstract: OBJECTIVE
  As there is a high prevalence of metabolic syndrome (MS) in the overweight population, their cardiovascular risk is also high and the review system in Spain appears to be inadequate. The present study was carried out to evaluate the quality of the medical care of these patients.
  
  
  METHODS
  Epidemiological, cross-sectional and multicenter study.
  
  
  METHODS
  
  
  
  METHODS
  A total of 138 primary care general practitioners from all over Spain included outpatients of both sexes, > 18 years old, with body mass index > or = 25 and with biochemical data from the last 6 months for fasting glucose, triglycerides, HDL-c and blood pressure.
  
  
  METHODS
  Self-evaluation, retrospective, internal and with data processing. Principal determinations: Degree of compliance of 12 evaluation criteria and description of MS factors.
  
  
  RESULTS
  A total of 2,280 patients were analysed. MS prevalence was 53.2%. Biochemical data were significantly higher in patients with MS and the most prevalent risk factors were: triglycerides > 150 (49.6%), systolic blood pressure > 140 (40.8%), fasting glucose > or = 126 (38.4%). Poor compliance of a few but relevant criteria was responsible for a high percentage of errors in the medical care quality.
  
  
  CONCLUSIONS
  Introduction of improvement activities in patients with MS in primary care is essential in the management and prevention of cardiovascular complications.
authors: Centro de Salud Buenavista Toledo, Grupo MAI-SEMG (Metodología y Apoyo a la Investigación, Sociedad Española de Medicina General), España. amodrego@sescam.jccm.es
authors: Angel
authors: A
authors: Modrego Navarro
authors: Manuel
authors: M
authors: Ramírez Espinosa
authors: Mariví
authors: M
authors: Fustero Fernández
authors: Pedro Juan
authors: PJ
authors: Tarraga López
authors: José Carlos
authors: JC
authors: Bastida Calvo
authors: Núria
authors: N
authors: Torras Tohà
mesh_terms: D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D003430:Cross-Sectional Studies; D004363:Drug Utilization; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood / Q000453:epidemiology* / Q000628:therapy; D008875:Middle Aged; D010045:Outpatients / Q000706:statistics & numerical data; D010349:Patient Compliance; D015995:Prevalence; D011320:Primary Health Care / Q000592:standards; D011787:Quality of Health Care; D012307:Risk Factors; D013030:Spain / Q000453:epidemiology
chemical_list: D000959:Antihypertensive Agents; D007004:Hypoglycemic Agents